0000899243-21-013955.txt : 20210330 0000899243-21-013955.hdr.sgml : 20210330 20210330184840 ACCESSION NUMBER: 0000899243-21-013955 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210326 FILED AS OF DATE: 20210330 DATE AS OF CHANGE: 20210330 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Fu Tao CENTRAL INDEX KEY: 0001644888 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38205 FILM NUMBER: 21788958 MAIL ADDRESS: STREET 1: 3175 HANOVER STREET CITY: PALO ALTO STATE: CA ZIP: 94304 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Zai Lab Ltd CENTRAL INDEX KEY: 0001704292 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: E9 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 4560 JINKE ROAD STREET 2: BLDG. 1, 4F, PUDONG CITY: SHANGHAI STATE: F4 ZIP: 201210 BUSINESS PHONE: 862161632588 MAIL ADDRESS: STREET 1: 4560 JINKE ROAD STREET 2: BLDG. 1, 4F, PUDONG CITY: SHANGHAI STATE: F4 ZIP: 201210 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-03-26 0 0001704292 Zai Lab Ltd ZLAB 0001644888 Fu Tao C/O ZAI LAB LIMITED 4560 JINKE ROAD, BLDG 1, 4TH FLOOR PUDONG, SHANGHAI F4 201210 CHINA 1 1 0 0 President & COO Ordinary Shares 2021-03-26 4 M 0 20000 18.92 A 207000 D Ordinary Shares 107500 I See footnote Stock Option (Right to Buy) 18.92 2021-03-26 4 M 0 20000 0.00 D 2028-09-24 Ordinary Shares 20000 480000 D The reported transaction was effected pursuant to a sales plan adopted by the Reporting Person expiring on September 15, 2021 and is intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. Shares held by the Reporting Person's spouse. The option vests in equal annual installments over five years beginning on 09/24/2019, the first anniversary of the date of grant. By: /s/ Bruce Blefeld, Attorney-in-Fact 2021-03-30